| NO. |
Chemical Name |
CAS NO. |
| Anti-migraine |
| Intermediates of Almotriptan |
| RM001 |
Almotriptan |
154323-57-6 |
| RM002 |
Almotriptan Malate |
181183-52-8 |
| RM003 |
4-(1-Pyrrolidinylsulfonylmethyl)benzene amine |
334981-10-1 |
| RM004 |
4-(1-Pyrrolidinylsulfonylmethyl) phenyl hydrazine monohydrochloride monohydrate |
334981-11-2 |
| N24HSWD (non-24-hour sleep–wake disorder) |
| Intermediates of Tasimelteon |
| RU001 |
4-ethenyl-2,3-dihydrobenzofuran |
230642-84-9 |
| BPH |
| Intermediates of Silodosin |
| RU002 |
2-[2-(2,2,2-Trifluoroethoxy)phenoxy]ethyl methanesulfonate |
160969-03-9 |
| RU003 |
5-[(2R)-2-Aminopropyl]-1-[3-(benzoyloxy)propyl]-2,3-dihydro-1H-indole-7-c arbonitrile (2R,3R)-2,3-dihydroxybutanedioate |
239463-85-5 |
| Intermediates of Alfuzosin, Terazosin, Doxazosin, Prazosin |
| RU004 |
2-Chloro-4-amino-6,7-dimethoxyquinazoline |
23680-84-4 |
| Anti-inflammatory |
| Intermediates of Mesalamine |
| RU005 |
5-nitrosalicylic acid |
96-97-9 |
| Anticonvulsant |
| Intermediates of Rufinamide |
| RU006 |
2,6-Difluorobenzylalcohol |
19064-18-7 |
| RU007 |
2,6-Difluorobenzyl chloride |
697-73-4 |
| RU008 |
2,6-Difluorobenzyl bromide |
85118-00-9 |
| RU009 |
Methyl (E)-3-methoxy-2-propenoate |
34846-90-7 |
| RU010 |
4-cyano-1-(2,6-difluorobenzyl)-1H-1,2,3-triazole |
202003-06-3 |
| Antihistamine |
| Intermediates of Epinastine Hydrochloride |
| RU011 |
(6,11-Dihydro-5H-dibenzo[b,e]azepin-6-yl)methanamine fumarate |
127785-96-0 |
| Intermediates of Bepotastine |
| RUB01 |
2-[(4-chlorophenyl)(4-piperidinyloxy)methyl]pyridine |
122368-54-1 |
| RUB02 |
2-[(4-chlorophenyl)-piperidin-4-yloxymethyl]pyridine,4-nitrobenzoate salt (1:1) |
161558-45-8 |
| RUB03 |
2-[(S)-(4-Chlorophenyl)(4-piperidinyloxy)methyl]pyridine L-Tartrate |
210095-58-2 |
| RUB04 |
2-[(S)-(4-Chlorophenyl)(4-piperidinyloxy)methyl]pyridine |
201594-84-5 |
| Antiemetic |
| Intermediates of Aprepitant |
| RU012 |
2-(R)-[1-(S)-(3,5-Bis(trifluoromethyl)phenyl)ethoxy]-3-(S)-fluorophenylmorpholine |
170729-79-0 |
| RU013 |
3-chloromethyl-1,2,4-triazolin-5-one |
252742-72-6 |
| Antimuscarinic |
| Intermediates of Fesoterodine Fumarate |
| RU014 |
R-(+)-2-(3-diisopropylamino-1-phenylpropyl)-4-hydroxymethylphenol fumaric acid salt (1:1) |
380636-50-0 |
| RU015 |
Benzoic acid, 3-[(1R)-3-[bis(1-methylethyl)amino]-1-phenylpropyl]-4-hydroxy-, methyl ester |
214601-17-9 |
| RU016 |
Benzoic acid, 3-[(1R)-3-[bis(1-methylethyl)amino]-1-phenylpropyl]-4-hydroxy-, methyl ester, hydrochloride (1:1) |
214600-45-0 |
| RU017 |
Benzoic acid, 3-[(1R)-3-[bis(1-methylethyl)amino]-1-phenylpropyl]-4-(phenylmethoxy)-, methyl ester |
156755-35-0 |
| RU018 |
Benzenemethanol, 3-[(1R)-3-[bis(1-methylethyl)amino]-1-phenylpropyl]-4-hydroxy- |
207679-81-0 |
| RU019 |
(R)-(-)-4-Benzyloxy-3-(3-diisopropylamino-1-phenylpropyl)-benzoic acid |
754159-68-7 |
| Intermediates of Mirabegron |
| RU020 |
(1R)-2-{[2-(4-Aminophenyl)ethyl]amino}-1-phenylethanol hydrochlor ide (1:1) |
521284-22-0 |
| RU021 |
2-(2-amino-1,3-thiazol-4-yl)acetic acid |
29676-71-9 |
| Antiepilepsy |
| Intermediates of Carbamazepine |
| RU028 |
Carbamazepine; 5-Carbamoyl-5H-dibenzo(b,f)azepine |
298-46-4 |
| Intermediates of Pregabalin |
| RU029 |
3-(Aminomethyl)-5-methyl-hexanoic acid |
148553-50-8 |
| RU030 |
(R)-(-)-3-(carbamoylmethyl)-5-methylhexanoic acid |
181289-33-8 |
| NSAID |
| Intermediates of Ketorolactromethamine |
| RU031 |
Diethyl 1,1-cyclopropanedicarboxylate |
1559-02-0 |
| Memery disorder |
| Intermediates of Citicoline Sodium |
| RU032 |
Cytidylic acid |
63-37-6 |
| RU033 |
1,3-dicyclohexyl urea |
2387-23-7 |
| ADHD |
| Intermediates of Atomoxetine |
| RU040 |
(N,N-Dimethyl-3-(2-methyl-phenyloxy)-3-phenyl-propanamine hydrochloride |
42064-62-0 |
